Found: 4
Select item for more details and to access through your institution.
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E185, doi. 10.1002/ajh.26504
- By:
- Publication type:
- Article
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 21, p. 3880, doi. 10.1002/cncr.34459
- By:
- Publication type:
- Article
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 4937, doi. 10.2147/OTT.S102504
- By:
- Publication type:
- Article